Irritable Bowel Syndrome Characterized by Constipation Clinical Trial
Official title:
A Phase 4, Single-centre, Randomised, Double-blind, Placebo-controlled, Parallel-group, Fixed-dose Study of the Effect of Linaclotide on Abdominal Girth in Participants With Irritable Bowel Syndrome With Constipation
The objective of this trial is to determine the effect of linaclotide on abdominal girth in IBS-C participants with the baseline symptoms of abdominal bloating and an increased abdominal girth.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01622972 -
Mode of Action of Moviprep
|
Phase 4 | |
| Recruiting |
NCT03687814 -
Low FODMAP Plus PEG 3350 for the Treatment of Patients With Irritable Bowel Syndrome-Constipation
|
N/A | |
| Completed |
NCT01722318 -
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
|
Phase 2 | |
| Recruiting |
NCT04214470 -
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in IBS
|
||
| Completed |
NCT02493452 -
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
|
Phase 3 | |
| Completed |
NCT03573908 -
A Trial of Linaclotide 290 μg in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
|
Phase 3 | |
| Completed |
NCT00948818 -
Trial of Linaclotide Administered to Patients With Irritable Bowel Syndrome With Constipation
|
Phase 3 | |
| Recruiting |
NCT03226145 -
Reclassifying Constipation Using Imaging and Manometry
|
N/A | |
| Completed |
NCT02732743 -
Food Supplement Physiomanna® Baby in Pediatric Patients
|
N/A | |
| Not yet recruiting |
NCT03923322 -
Botanical Tincture for Symptoms of Irritable Bowel Syndrome
|
Phase 2 | |
| Completed |
NCT02387359 -
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
|
Phase 3 |